 SAN DIEGO , Sept. 2, 2022 PRNewswire -- Regulus Therapeutics Inc. Nasdaq: RGLS, a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs the Company or Regulus, today announced that the Company will participate in two upcoming investor conferences. 